Clinical Trial Update: Abbott Atrial Fibrillation Post Approval Study

View source ↗

Summary

Abbott's post-approval atrial fibrillation study is active but not recruiting, indicating ongoing post-market surveillance of the device.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Arrhythmia
• Atrial Fibrillation
• Atrial Tachycardia

Drugs mentioned

• Abbott AF Device

Snippet

Sponsor: Abbott Medical Devices | Conditions: Atrial Arrhythmia, Atrium; Fibrillation | Status: ACTIVE_NOT_RECRUITING